PRESS RELEASE
21 August 2023

MoFo Advises Examinetics On Inaugural Investment By Coalesce

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Morrison Foerster advised Examinetics in connection with an inaugural investment by Coalesce Capital (“Coalesce”), a private equity firm focused on business services. Freedom 3 Capital...
United States

Morrison Foerster advised Examinetics in connection with an inaugural investment by Coalesce Capital ("Coalesce"), a private equity firm focused on business services. Freedom 3 Capital, an investment management firm and an existing Examinetics capital provider, teamed up with Coalesce to recapitalize Examinetics.

Examinetics is a leading provider of occupational health compliance testing services. Coalesce's investment in Examinetics is expected to enable the company to further accelerate its expansion in existing and new markets, as well as introduce new technologies and services to meet the complex regulatory requirements facing its clients.

The MoFo deal team advising Examinetics was led by New York corporate partners Mitchell Presser and Aly El Hamamsy, and Boston corporate of counsel Kevin Madden, together with Miami corporate associate Bill Halaby, Washington, D.C. corporate associate Shams Haidari, and Denver corporate associate Hardin Cox.

The wider team included New York executive compensation partner Domnick Bozzetti and New York tax partner Dave Sturgeon.

Read more about the transaction in Coalesce's press release.

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More